Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 439, 533 (2 February 2006) | doi:10.1038/439533a; Published online 1 February 2006
Ticking the right boxes
Colin Macilwain
Top of page
Abstract
Probing parasite's evasive tricks could herald novel anti-inflammatory compounds.
The humble tick isn't often viewed as an ally of human health (see page 524), but one British biotechnology company is banking on its hidden charms.Reading-based Evolutec holds patent rights on a number of proteins found in the saliva of ticks, and some are already showing clinical promise, particularly for the treatment of allergies and inflammation.
To read this story in full you will need to login or make a payment (see right).